Endocrinology, Vol 133, 705-712, Copyright © 1993 by Endocrine Society

ARTICLES

Modification of insulin resistance by diazoxide in obese Zucker rats

R Alemzadeh, AE Slonim, MM Zdanowicz and J Maturo
Department of Pediatrics, North Shore University Hospital-Cornell University Medical College, Manhasset, New York 11030.

Hyperinsulinism, insulin resistance, and decreased number of insulin receptors are characteristic of obesity in both humans and experimental animals. To assess the role of insulin in developing obesity, diazoxide (DZ), an inhibitor of glucose-stimulated insulin secretion, was administered for 8 weeks to 7-week-old female Zucker rats in two concentrations, 50 mg/kg.day (LD-DZ), and 100 mg/kg.day (HD-DZ). The obese and lean rats were divided into three subgroups: diazoxide (DZ), pair-fed (PF), and control (C) groups (n = 6 rats/subgroup-genotype). Diazoxide-treated obese and lean animals showed significantly lower postabsorptive plasma insulin concentrations (P < 0.005) than their respective obese and lean PF and C subgroups. HD-DZ obese rats consumed more calories (P < 0.001), yet gained less weight (P < 0.05) than PF and C rats. The plasma glucose concentrations in the postabsorptive state and during glucose tolerance tests in HD-DZ obese rats were significantly lower than those in PF and C rats (P < 0.01) despite a decrease in their plasma insulin concentrations (P < 0.01), whereas HD- DZ lean rats displayed a diabetic response (P < 0.01). The adipocyte- specific insulin receptor binding was dose-dependently increased in both lean and obese DZ animals (P < 0.01). DZ had a dual effect on insulin metabolism; it decreased insulin secretion and increased insulin receptor binding. This dual effect was associated with improved glucose tolerance and a decrease in weight gain in obese rats.

This article has been cited by other articles:

				M. B. Zemel The Role of Dairy Foods in Weight Management J. Am. Coll. Nutr., December 1, 2005; 24(suppl_6): 537S - 546S. [Abstract] [Full Text] [PDF]

				R. Alemzadeh and K. M. Tushaus Modulation of Adipoinsular Axis in Prediabetic Zucker Diabetic Fatty Rats by Diazoxide Endocrinology, December 1, 2004; 145(12): 5476 - 5484. [Abstract] [Full Text] [PDF]

				L. E. Fridlyand and L. H. Philipson Does the Glucose-Dependent Insulin Secretion Mechanism Itself Cause Oxidative Stress in Pancreatic {beta}-Cells? Diabetes, August 1, 2004; 53(8): 1942 - 1948. [Abstract] [Full Text] [PDF]

				R. D. Carr, C. L. Brand, T. B. Bodvarsdottir, J. B. Hansen, and J. Sturis NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat Diabetes, October 1, 2003; 52(10): 2513 - 2518. [Abstract] [Full Text] [PDF]

				M. B. Zemel Mechanisms of Dairy Modulation of Adiposity J. Nutr., January 1, 2003; 133(1): 252S - 256. [Abstract] [Full Text] [PDF]

				K. E. Cosgrove, M.-H. Antoine, A. T. Lee, P. D. Barnes, P. de Tullio, P. Clayton, R. McCloy, P. De Lonlay, C. Nihoul-Fekete, J.-J. Robert, et al. BPDZ 154 Activates Adenosine 5'-Triphosphate-Sensitive Potassium Channels: In Vitro Studies Using Rodent Insulin-Secreting Cells and Islets Isolated from Patients with Hyperinsulinism J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4860 - 4868. [Abstract] [Full Text] [PDF]

				M. STANDRIDGE, R. ALEMZADEH, M. ZEMEL, J. KOONTZ, and N. MOUSTAID-MOUSSA Diazoxide down-regulates leptin and lipid metabolizing enzymes in adipose tissue of Zucker rats FASEB J, March 1, 2000; 14(3): 455 - 460. [Abstract] [Full Text]

				H. SHI, N. MOUSTAID-MOUSSA, W. O. WILKISON, and M. B. ZEMEL Role of the sulfonylurea receptor in regulating human adipocyte metabolism FASEB J, October 1, 1999; 13(13): 1833 - 1838. [Abstract] [Full Text]

				R. Alemzadeh and S. Holshouser Effect of Diazoxide on Brain Capillary Insulin Receptor Binding and Food Intake in Hyperphagic Obese Zucker Rats Endocrinology, July 1, 1999; 140(7): 3197 - 3202. [Abstract] [Full Text]

				R. Alemzadeh, G. Langley, L. Upchurch, P. Smith, and A. E. Slonim Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1911 - 1915. [Abstract] [Full Text]